Warning: Cannot modify header information - headers already sent by (output started at D:\InetPub\vhosts\sourcejuice\wp-config.php:1) in D:\InetPub\vhosts\sourcejuice\wp-content\themes\classic\postdetail_new2.php on line 3
Asia-Pacific Yixie higher than the global growth of the market into the fast lane

Asia-Pacific Yixie higher than the global growth of the market into the fast lane

The next 3 years, the medical device market in Asia Pacific will grow at a rate of over 10%. This growth rate is higher than the global medical device industry forecast growth rate of 6%. Health care institutions in the safe, reliable and cost-effective method of treatment more demanding, and consumers demanding better medical products, driven by major factors, the medical device market in Asia Pacific will be rapid growth.
Currently, the Asia-Pacific region about the size of the medical device market is 550 billion U.S. dollars, accounting for the global medical device market (2300 billion U.S. dollars) roughly one-quarter. Medical device manufacturers more optimistic about the diabetes-related disease, and cardiovascular, orthopedic and infectious disease therapeutic areas of potential opportunity.

In order to promote the development of the medical device market, the majority of Asia-Pacific countries are on the medical device product approval and manufacturing practices to adopt more stringent regulatory policies.

One example is Malaysia. The basis of the country in 2008 "medical devices" the establishment of the first set of medical device regulations. In Malaysia, the medical device product registration is not mandatory. However, over time, is expected to be introduced in Malaysia more about the medical equipment production and import laws and regulations.

Malaysia's medical device market is the middle level, the value of about 6 billion U.S. dollars; 90% of the medical equipment imported from abroad, mostly from the United States. Imports of medical equipment in Malaysia, the U.S. medical device maker's share of more than 25%.

Japan: strong demand for breast screening

As of 2020, Japan the number of women suffering from breast cancer cases are expected to increase by 25%, which is higher than the same period the United States and the EU forecast growth rate of 14%. Sharp increase in incidence is a major cause of environmental pollution in Japan and the female hormone levels. The Japanese women lack of exercise and changes in dietary patterns also had an important role.

Since 1999, breast cancer mortality rate has been rising in Japan. At present, the Japanese women because of the total cases of cancer death in the proportion of breast cancer is about 9%, compared to 7% in 1999 increased. However, the Japanese women's breast cancer mortality and other cancer mortality rates are still lower than the U.S. ratio of 15%. In Japan, delayed diagnosis of breast cancer is a major cause increased mortality.

In Japan, a common way breast cancer screening breast X-ray photography. However, relative to 50-year-old Japanese woman, the breast X-ray screening is not easy to find 40-year-old Japanese woman suffering from breast cancer. This is because the 40-year-old female has a more thick and dense breast tissue, which makes X-ray photography by breast cancer more difficult to find.

In recent years, a more effective screening method in Japan and the United States and Europe, is increasingly recognized, this is the ultrasound elasticity imaging. The use of tissue elasticity imaging technology that ultrasonic devices through the clinical diagnosis of breast disease. Studies have shown that in the identification of malignant and benign breast lesions, the ultrasound elastography of breast X-ray photography is more than effective. But in other parts of Asia, ultrasound elasticity imaging for diagnosis of breast cancer at an early research stage effect.

India: diagnostics business to grow 20%

The next 3 years, the Indian diagnostics business that is expected to grow about 20% growth to the end of 2013, medical diagnostic products market will reach about 20 billion U.S. dollars.

India 5% of the GDP into health care fields, the proportion is much lower than 15% of the United States. However, the government and private healthcare sectors to invest in the cost of increasing health care expenses in India will grow. Promote the development of health care services and other factors include the growing number of high-income strata, requiring a more comprehensive health care services and health insurance policyholders more and more and so on.

Medical institutions in India, more than two-thirds of medical practices based on local diagnostic services, including the pathology laboratory for testing. India has around 100,000 diagnostic laboratory, which is approximately equivalent to half of the United States. India's testing lab in the amount of difference in the larger, regional laboratories and hospital laboratories can do hundreds of times a day for testing, a large laboratory can do every day from 2000 to 3000 for testing.

Diagnostic services in India (including molecular diagnostics and other specialized tests) are usually cheaper than most developed countries. However, India's most laboratories in the private sector has not been certified because the certification is not mandatory in India.